| 000 | 01620 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513124920.0 | ||
| 264 | 0 | _c19970930 | |
| 008 | 199709s 0 0 eng d | ||
| 022 | _a0014-2980 | ||
| 024 | 7 |
_a10.1002/eji.1830270834 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBuzyn, A | |
| 245 | 0 | 0 |
_aPeptides derived from the whole sequence of BCR-ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes. _h[electronic resource] |
| 260 |
_bEuropean journal of immunology _cAug 1997 |
||
| 300 |
_a2066-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 |
_aBinding Sites _xgenetics |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCell Line, Transformed |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xgenetics |
| 650 | 0 | 4 |
_aHLA Antigens _xmetabolism |
| 650 | 0 | 4 |
_aHLA-B7 Antigen _xmetabolism |
| 650 | 0 | 4 | _aHerpesvirus 4, Human |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class I _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xgenetics |
| 650 | 0 | 4 |
_aPeptide Fragments _xgenetics |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aOstankovitch, M | |
| 700 | 1 | _aZerbib, A | |
| 700 | 1 | _aKemula, M | |
| 700 | 1 | _aConnan, F | |
| 700 | 1 | _aVaret, B | |
| 700 | 1 | _aGuillet, J G | |
| 700 | 1 | _aChoppin, J | |
| 773 | 0 |
_tEuropean journal of immunology _gvol. 27 _gno. 8 _gp. 2066-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/eji.1830270834 _zAvailable from publisher's website |
| 999 |
_c9273641 _d9273641 |
||